Delivery Order SPE2DB22D2206-SPE2DB25FJV10
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency on August 28, 2025, for the supply of Revlimid 25 mg capsules (100-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be performed at the awardee's Conshohocken location. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $53,251.31 for Revlimid 15 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency for the supply of Revlimid 25 mg capsules (100-count units). The award, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract was competitively awarded and will be performed at the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Revlimid 25 mg capsule medication. The $20,562.98 contract has an ultimate completion date of April 24, 2024 and was awarded on April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (21-count packages) under a firm fixed-price contract with a ceiling value of $32,771.71. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 4, 2025, with fulfillment performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Revlimid 10 mg capsules (100-count units) with a ceiling value of $52,575.49. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $19.85K firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (21-count packaging) on September 8, 2025, with completion required by September 29, 2025. This non-set-aside competitive award supports federal pharmaceutical procurement needs, with performance taking place at the contractor's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $105,150.98 for Revlimid 10 mg capsules (100-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $12,329.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 28-count bottles of Revlimid 5 mg capsules, with an ultimate completion date of September 23, 2025. This non-set-aside competitive award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Revlimid is an immunomodulatory medication commonly used in the treatment of multiple myeloma and other...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV10Delivery Order
The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA encompasses a comprehensive range of pharmaceutical products across multiple therapeutic domains. This delivery order for Revlimid, a specialty medication, exemplifies AmerisourceBergen's role in supplying brand-name and generic drugs to support Defense Health Agency operations and other government healthcare systems through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 9/8/25 |